Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bingqiong Wang
Observed names:
WANG Bingqiong,
Wang, Bingqiong,
bingqiong wang
Institutions:
Capital Medical University,
National Clinical Research Center for Digestive Diseases,
Beijing Friendship Hospital
Observed institutions:
Capital Medical University,
National Clinical Research Center for Digestive Diseases,
Beijing Friendship Hospital
ORCID:
0009-0005-3439-6810
Observed ORCID:
0009-0005-3439-6810
OpenAlex ID:
A5110973946
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
2016
·
Yameng Sun
, Jialing Zhou
, et al.
·
Hepatology
·
182
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy
2020
·
Yameng Sun
, Xiaoning Wu
, et al.
·
Clinical Gastroenterology and Hepatology
·
154
PDF
Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation
2021
·
Shanshan Wu
, Na Zeng
, et al.
·
Clinical Gastroenterology and Hepatology
·
71
Dynamics of elastin in liver fibrosis: Accumulates late during progression and degrades slowly in regression
2019
·
Wei Chen
, Xuzhen Yan
, et al.
·
Journal of Cellular Physiology
·
45
Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events
2023
·
Yameng Sun
, Wei Chen
, et al.
·
Clinical Gastroenterology and Hepatology
·
34
Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study
2018
·
Xiaoning Wu
, Yiwen Shi
, et al.
·
Expert Opinion on Biological Therapy
·
32
Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding
2023
·
Zhiying He
, Bingqiong Wang
, et al.
·
Hepatology International
·
28
Comparison of fibrosis regression of entecavir alone or combined with pegylated interferon alpha2a in patients with chronic hepatitis B
2021
·
Shuyan Chen
, Jialing Zhou
, et al.
·
Hepatology International
·
25
Platelets’ increase is associated with improvement of liver fibrosis in entecavir-treated chronic hepatitis B patients with significant liver fibrosis
2018
·
Lin Wang
, Bingqiong Wang
, et al.
·
Hepatology International
·
21
Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients
2018
·
Bingqiong Wang
, Yameng Sun
, et al.
·
Modern Pathology
·
21
PDF
Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis
2021
·
Xiaoning Wu
, Jia Hong
, et al.
·
Hepatology International
·
19
Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
2019
·
Xiaoning Wu
, Jialing Zhou
, et al.
·
Infection and Drug Resistance
·
19
PDF
Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China
2022
·
Xinyu Zhao
, Min Li
, et al.
·
Journal of Clinical and Translational Hepatology
·
18
PDF
The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosis
2023
·
Xiujuan Chang
, Caihong Lv
, et al.
·
Hepatology
·
16
Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients
2023
·
Xiaoning Wu
, Xiaoqian Xu
, et al.
·
Clinical and Molecular Hepatology
·
16
PDF
Crosstalk of lysyl oxidase-like 1 and lysyl oxidase prolongs their half-lives and regulates liver fibrosis through Notch signal
2024
·
Ning Zhang
, Aiting Yang
, et al.
·
Hepatology Communications
·
15
Two-year free of complications during antiviral therapy predicts stable re-compensation in immediate-treatment HBV-related decompensated cirrhosis
2022
·
Zhiying He
, Jialing Zhou
, et al.
·
Scandinavian Journal of Gastroenterology
·
15
SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies
2019
·
Bingqiong Wang
, Yameng Sun
, et al.
·
Hepatology International
·
15
PDF
Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
2024
·
Chuan Liu
, Hong You
, et al.
·
Clinical and Molecular Hepatology
·
14
PDF
Persistent steatosis correlates with decreased fibrosis regression during anti‐HBV treatment in patients with chronic HBV infection
2023
·
Mengyang Zhang
, Shuyan Chen
, et al.
·
Journal of Medical Virology
·
12
PDF
Comparative Performance of 14 HCC Prediction Models in CHB: A Dynamic Validation at Serial On-Treatment Timepoints
2022
·
Shanshan Wu
, Jialing Zhou
, et al.
·
The American Journal of Gastroenterology
·
11
Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment
2025
·
Mengyang Zhang
, Shuyan Chen
, et al.
·
Nature Communications
·
9
PDF
Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments
2024
·
Shuyan Chen
, Jialing Zhou
, et al.
·
Hepatology International
·
9
A new glutamine synthetase index to evaluate hepatic lobular restoration in advanced fibrosis during anti‐HBV therapy
2023
·
Shuyan Chen
, Bingqiong Wang
, et al.
·
Journal of Medical Virology
·
9
PDF
Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy
2021
·
Xiaoning Wu
, Jialing Zhou
, et al.
·
Hepatology International
·
9
Show more works
View as search
Works count:
53
Citation count:
862
H-index:
15
I10-index:
21
Year
Topic
Type